Early Phase 2a data suggest the IPF therapy GRI-0621 alters gene activity tied to inflammation, scarring, and tissue repair.
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...
A new review published in Genes & Diseases highlights the transformative role of microRNAs (miRNAs) in regulating and potentially reversing adipose tissue fibrosis, a condition closely linked to ...
Fibrosis of the lungs is often a silent disease until it's too late. By the time patients are diagnosed, the scarring of their lung tissue is already advanced, and current treatments offer little more ...
Gene Expression Data Show Direct Impact on the Core Biology of IPF ...
Why does the face scar less than the rest of the body? New research uncovers the cellular pathway behind this difference.
Ashlee Ford Versypt hopes the work will allow physicians to better predict how to promote regeneration across different tissue systems in the body.
Congenital hepatic fibrosis is a type of liver disease that is present from birth. It typically affects the function of the bile ducts and the veins that carry blood from the digestive tract to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results